# Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cyclooxygenase-2-selective-non-steroidal-anti-inflammatory-drugs-etodolac/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yen‐Fu Chen,Paresh Jobanputra,Pelham Barton,Sara E. Bryan,A Fry-Smith,Gerald J. Harris,Robert Taylor |
| Citations | 338 |
| DOI | 10.3310/hta12110 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://njl-admin.nihr.ac.uk/document/download/2001581 |
| OpenAlex ID | https://openalex.org/W1988145586 |
| PMID | 18405470 |
| Type | review |
| Year | 2008 |

## Paper authors

- [Yen‐Fu Chen](https://scholariq.org/researchers/yen-fu-chen/)

## Paper journal

- [Health Technology Assessment](https://scholariq.org/journals/health-technology-assessment/)

## Paper primary topic

- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)

## Paper topics

- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)
- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.